+ A
A -
Tribune News Network
Doha
Dr. Naila Rabbani, Professor of Basic Medical Sciences at the College of Medicine, Qatar University, and Dr. Paul Thornalley, Director of the Diabetes Research Center at the Qatar Biomedical Research Institute, Hamad Bin Khalifa University (HBKU), co-hosted the Symposium of the European Association for the Study of Diabetes (EASD) Reactive Metabolite Study Group (RSMG). As part of the EASD 2020 virtual conference on Wednesday, they chaired the symposium.
The Reactive Metabolites Study Group (RMSG) Symposium focused on mathematical metabolic modeling to predict the risk of insulin resistance and diabetic vascular complications. The speakers at the symposium were: Dr. Nicola Lai (University of Cagliari, Italy) and Dr. Alberto de la Fuente (QBRI, HBKU). They presented updates on the mathematical modeling of metabolic dysfunction associated with the development of vascular complications of diabetes.
Dr. Naila said: “This symposium has presented and discussed recent advancement made by researchers at QU and QBRI on key metabolic drivers of insulin resistance and diabetic vascular complications. With mathematical regulatory models, we can identify key mechanistic biomarkers for risk prediction of development of type 2 diabetes and diabetic vascular complications to support precision medicine”.
Dr. Thornalley said: “We are excited that we presented collaborative research from Qatar to a global audience at the EASD2020 conference.”
The Reactive Metabolites Study Group (RMSG) Symposium is part of the 56th Annual Meeting of the EASD. The five-day conference, which started on September 21 and will end on September 25, will highlight the latest results in diabetes and related research. The virtual event is expected to attract more than 17,000 participants from the global medical community.
Doha
Dr. Naila Rabbani, Professor of Basic Medical Sciences at the College of Medicine, Qatar University, and Dr. Paul Thornalley, Director of the Diabetes Research Center at the Qatar Biomedical Research Institute, Hamad Bin Khalifa University (HBKU), co-hosted the Symposium of the European Association for the Study of Diabetes (EASD) Reactive Metabolite Study Group (RSMG). As part of the EASD 2020 virtual conference on Wednesday, they chaired the symposium.
The Reactive Metabolites Study Group (RMSG) Symposium focused on mathematical metabolic modeling to predict the risk of insulin resistance and diabetic vascular complications. The speakers at the symposium were: Dr. Nicola Lai (University of Cagliari, Italy) and Dr. Alberto de la Fuente (QBRI, HBKU). They presented updates on the mathematical modeling of metabolic dysfunction associated with the development of vascular complications of diabetes.
Dr. Naila said: “This symposium has presented and discussed recent advancement made by researchers at QU and QBRI on key metabolic drivers of insulin resistance and diabetic vascular complications. With mathematical regulatory models, we can identify key mechanistic biomarkers for risk prediction of development of type 2 diabetes and diabetic vascular complications to support precision medicine”.
Dr. Thornalley said: “We are excited that we presented collaborative research from Qatar to a global audience at the EASD2020 conference.”
The Reactive Metabolites Study Group (RMSG) Symposium is part of the 56th Annual Meeting of the EASD. The five-day conference, which started on September 21 and will end on September 25, will highlight the latest results in diabetes and related research. The virtual event is expected to attract more than 17,000 participants from the global medical community.
